Kawasaki disease: an update on diagnosis and treatment. | Semantic Scholar
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
The Role of Neutrophil Activation in the Pathogenesis of Kawasaki Disease | Insight Medical Publishing
Treatment Options for Refractory Kawasaki Disease
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
Diagnosis and Management of Kawasaki Disease | AAFP
Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST | Pediatric Research
Frontiers | A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
IJMS | Free Full-Text | Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Clinical characteristics in Kawasaki disease related to intravenous... | Download Table
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Clinical Practice Guidelines : Kawasaki disease
Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease | MDedge Pediatrics
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness | PLOS ONE
JCI - Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
Understanding Kawasaki Disease
Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial | Trials | Full Text
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
